Home »
When a patient arrives at a hospital with an infection, her doctor must decide which antibiotic might have the best chance of curing her—no easy feat when disease-causing pathogens are increasingly resistant to multiple antibiotics. For that reason, hospitals often track the antibiotic resistance profiles of infectious microbes that they isolate from sick patients, which […]
STAMFORD, Conn. – March 28, 2019 – Imbrium Therapeutics L.P., a clinical-stage biopharmaceutical company and operating subsidiary of Purdue Pharma L.P., in conjunction with Mundipharma EDO GmbH, today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to its investigational drug tinostamustine, a potentially first-in-class alkylating deacetylase inhibiting molecule […]
March 27, 2019 — The U.S. Food and Drug Administration today approved Jatenzo (testosterone undecanoate), an oral testosterone capsule to treat men with certain forms of hypogonadism. These men have low testosterone levels due to specific medical conditions, such as genetic disorders like Klinefelter syndrome or tumors that have damaged the pituitary gland. Jatenzo should […]
With more than 2 million Americans suffering from an opioid use disorder and the escalating rate of deaths from opioid overdoses reaching about 130 per day, efforts to date have had little impact in curbing this crisis across the country. As a result, a committee of the National Academies of Sciences, Engineering and Medicine released […]
A team of researchers from Spain, the U.S. and the Netherlands has found that giving people propofol can lead to muddied memory recall of specific incidents. In their paper published in the journal Science Advances, the group describes experiments they conducted with volunteers undergoing colonoscopy and what they found. Memories can be both a blessing […]
DUBLIN, March 18, 2019 /PRNewswire/ — Allergan plc (NYSE: AGN) today announced that the U.S. Food and Drug Administration (FDA) has approved the company's supplemental New Drug Application (sNDA) for Avycaz (ceftazidime and avibactam), expanding the label to include pediatric patients 3 months and older for the treatment of complicated intra-abdominal infections (cIAI) in combination […]
SAN JOSE, Calif., Feb. 28, 2019 /PRNewswire/ — The first human study of a pill designed to replace injections of biologics is today being announced by Rani Therapeutics, the inventor of the RaniPill™ capsule. The human study follows more than 100 animal studies testing the RaniPill capsule's delivery of drugs such as insulin and Humira […]
An increasing proportion of all cardiac arrests occurring outside of the hospital are related to drug overdoses, according to a new study conducted by two University of Arizona College of Medicine – Phoenix students. Fourth-year medical student Gabriella Smith and second-year medical student Sam Beger co-authored a manuscript showing that 15 people suffer sudden cardiac […]
Shortages of essential chemotherapy drugs for children undergoing cancer treatment has been an increasingly frequent obstacle for patients and hospitals across the country. In a new position paper in JAMA Pediatrics, Baylor College of Medicine’s Drs. Stacey Berg and Brooke Bernhardt address this issue and call for the development of an essential medicines list for […]
Many antibiotic courses prescribed for common infections treated in English primary care (general practices and community services) exceed the recommended guidelines, reveals a study in The BMJ today. Treatment courses were 1.3 million days beyond the durations recommended by guidelines, with most excess days due to treatment for respiratory conditions. Previous studies have found significant […]